my country independently develops a variety of effective drugs for the new coronavirus

my country independently develops a variety of effective drugs for the new coronavirus

my country independently develops a variety of effective drugs for new coronaviruses my country independently develops multiple effective drugs for new coronaviruses

CCTV News: The number of mutations of the new crown virus has increased and the variant strains are prevalent in many countries.
While the new crown vaccine has achieved effective prevention and control, the demand for effective drugs for the new crown virus has become more and more urgent
.

Where is the development of effective drugs for the new coronavirus in my country, and what are the candidate "seed drugs"? Next, let us take a look at the development of China's new crown drugs

After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks.
On February 16, 2020, set up a scientific research team composed of the Ministry of Science and Technology, the Health Commission, the Ministry of Industry and Information Technology, the Development and Reform Commission, the Food and Drug Administration, the Bureau of Traditional Chinese Medicine and other departments.
, Organize a national team of superior experts to focus on clinical treatment needs, and make every effort to promote the research and development of effective drugs and treatment technologies
.

According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds

The new coronavirus is a brand-new virus.
There is still no conclusion about which drug can hit its "seven inches" and which "blocking" strategy can work
.

To this end, China has deployed three technical routes during the development of new coronavirus drugs

The three technical routes have their own characteristics, and adopt different strategies to "block" the different physiological links of the new coronavirus infection of the human body
.

Take the inhibition of virus replication as an example.

Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
A batch of key drugs such as injections
.

A variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment

Focus on the new crown pneumonia epidemic